From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Abstract Text:

Elizabeth J Want,Anders ,Hirotoshi Morita,Gary Siuzdak,

Mass spectrometry (MS) is an established technology in drug metabolite analysis and is now expanding into endogenous metabolite research. Its utility derives from its wide dynamic range, reproducible quantitative analysis, and the ability to analyze biofluids with extreme molecular complexity. The aims of developing mass spectrometry for metabolomics range from understanding basic biochemistry to biomarker discovery and the structural characterization of physiologically important metabolites. In this review, we will discuss the techniques involved in this exciting area and the current and future applications of this field.

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Publishing Authors By Initials

EJ Want,A ,H Morita,G Siuzdak,

For similar proteins: proteome research abstracts see: proteins: proteome research

PUBMED ID PMID:

MEDLINE DATE:

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Journal Published:

PUBLICATION TYPE: Review

Journal: Journal of proteome research

VOLUME: 6

Page Numbers: 459-68

Journal Abbreviation: J. Proteome Res.

ISSN: 1535-3893

DAY: 3

MONTH: Feb

YEAR: 2007

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Information

Number of References: 120

LANGUAGE: eng

NlmUniqueID: 101128775

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Keywords Mesh Terms:

KEYWORDS: Proteome

MESH TERMS: metabolism

Chemical & Substance for Abstract: From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. Information

Substance Name: Proteome

Registry Number: 0

Grant and Affiliation Information for From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.

AFFILIATION: Department of Molecular Biology, The Scripps Center for Mass Spectrometry, 10550 North Torrey Pines Road, La Jolla, CA 92037, USA.

Country: United States

AGENCY: United States NIMH

GRANT: MH 062261

ACRONYM: MH

MEDLINETA: J Proteome Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics Related Publications

• A nanostructure-initiator mass spectrometry-based enzyme activity assay.
• Clathrate nanostructures for mass spectrometry.
• Correlating the transcriptome, proteome, and metabolome in the environmental adaptation of a hyperthermophile.
• Desorption/ionization on silicon nanowires.
• From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics.
• High surface area of porous silicon drives desorption of intact molecules.
• Mass spectrometry reveals specific and global molecular transformations during viral infection.
• Metabolomics identifies perturbations in human disorders of propionate metabolism.
• Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice.
• Nanostructure-initiator mass spectrometry: a protocol for preparing and applying NIMS surfaces for high-sensitivity mass analysis.
• Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum.
• Selective metabolite and peptide capture/mass detection using fluorous affinity tags.
• Sepsis plasma protein profiling with immunodepletion, three-dimensional liquid chromatography tandem mass spectrometry, and spectrum counting.
• XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization.